EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MiR-145 Alleviates Sepsis-Induced Inflammatory Responses and Organ Injury by Targeting ADAM17

Yingying Lin, Lizhen Liu, Yao Lin, Ruoxuan Yang, Shuanglin Liao, Mingwei Xu, Junbing He, Qinghua Liu

Frontiers in Bioscience-Landmark · 23.01.2024 · 29 (1)

DOI: 10.31083/j.fbl2901044 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 23.01.2024. Verfasst von Yingying Lin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Jieyang Medical Research Center, Jieyang People's Hospital, 522000 Jieyang, Guangdong, China. Hauptthemen laut MEDLINE: ADAM17 Protein, MicroRNAs, Sepsis. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Scientific Research Foundation of Guangdong Province, Science and Technology Innovation Leading talents Project of Jieyang City, Natural Science Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Current studies have demonstrated that disintegrin and metalloproteinase 17 (ADAM17) plays a critical role in the pathogenesis of sepsis. MicroRNA (miR)-145 is known to control immune responses as an anti-inflammatory modulatory molecule. However, a fundamental understanding of how miR-145 regulates ADAM17 and, more broadly, sepsis-induced inflammatory response remains unknown.

Methods

We used western blotting and quantitative real-time PCR (qRT-PCR) to measure expression levels of ADAM17 and miR-145. Enzyme-linked immunosorbent assays (ELISA) were performed to measure cytokine production. To determine if ADAM17 is a target gene of miR-145, bioinformatics analyses and luciferase reporter assays were conducted. The impacts of ADAM17 and miR-145 on sepsis-induced inflammatory responses were accessed in vitro using human umbilical endothelial cells (HUVECs) treated with lipopolysaccharide (LPS). Sepsis-induced inflammatory response was measured in vivo using a polymicrobial septic mouse model induced by cecal ligation and puncture (CLP) with pre-injection of a miR-145 agomir.

Results

In HUVECs treated with LPS, miR-145 expression was downregulated and miR-145 negatively regulated ADAM17 expression through direct binding to the ADAM17 transcript 3′-UTR. MiR-145 overexpression markedly reduced LPS-induced inflammatory cytokine production by targeting ADAM17 in HUVECs. In comparison to CLP-induced septic mice treated with a control agomir, treatment with a miR-145 agomir significantly reduced the expression of ADAM17, numerous downstream cytokines such as IL-6, TNF-α, IL-1β and MCP-1, and the endothelial injury factors ICAM-1, VCAM-1. The miR-145 agomir also alleviated acute lung and kidney injury and improved the survival rate of septic mice.

Conclusions

This study showed that miR-145, by specifically targeting ADAM17, negatively regulates sepsis-induced inflammatory responses and vascular endothelial injury, and ultimately improved organ injury and survival during sepsis. The underlying mechanism for the regulation of ADAM17 expression by miR-145 and sepsis-induced inflammatory reactions may offer sepsis patients a novel therapeutic option.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ADAM17 ProteinMicroRNAsSepsisAnimalsHumansMiceApoptosisCytokinesEndothelial Cells

Stichwörter der Autor:innen

ADAM17inflammationmiR-145organ injurysepsisvascular endothelial injury

Substanzen

ADAM17 ProteinADAM17 protein, humanCytokinesMicroRNAsMIRN145 microRNA, human

Autor:innen und Institutionen

  • Jieyang Medical Research Center, Jieyang People's Hospital, 522000 Jieyang, Guangdong, China.
  • The Intensive Care Unit, Affiliated Hospital of Guangdong Medical University, 524002 Zhanjiang, Guangdong, China.
  • Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, 510080 Guangzhou, Guangdong, China.
  • NHC Key Laboratory of Clinical Nephrology (Sun Yat-Sen University) and Guangdong Provincial Key Laboratory of Nephrology, 510080 Guangzhou, Guangdong, China.

Förderung

  • Medical Scientific Research Foundation of Guangdong Province
  • Science and Technology Innovation Leading talents Project of Jieyang City
  • Natural Science Foundation of Guangdong Province
  • Science and Technology Project of Jieyang City

Zitieren

APA

Lin, Y., Liu, L., Lin, Y., Yang, R., Liao, S., Xu, M., He, J., & Liu, Q. (2024). MiR-145 Alleviates Sepsis-Induced Inflammatory Responses and Organ Injury by Targeting ADAM17. Frontiers in Bioscience-Landmark, 29(1). https://doi.org/10.31083/j.fbl2901044

Vancouver

Lin Y, Liu L, Lin Y, Yang R, Liao S, Xu M, et al. MiR-145 Alleviates Sepsis-Induced Inflammatory Responses and Organ Injury by Targeting ADAM17. Frontiers in Bioscience-Landmark. 2024;29(1). doi:10.31083/j.fbl2901044

BibTeX
@article{Lin2024,
  author = {Lin, Yingying and Liu, Lizhen and Lin, Yao and Yang, Ruoxuan and Liao, Shuanglin and Xu, Mingwei and He, Junbing and Liu, Qinghua},
  title = {MiR-145 Alleviates Sepsis-Induced Inflammatory Responses and Organ Injury by Targeting ADAM17},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2024},
  volume = {29},
  number = {1},
  doi = {10.31083/j.fbl2901044}
}
Kostenlos starten →